… aspirin for secondary prevention of cardiovascular disease (class I, level A recommendation),
and clopidogrel as an alternative in case of aspirin … Particularly in patients with high risk …

… in patients with stable cardiovascular disease. The main strength in comparison with previous
analyses is that the study incorporates evidence not only with clopidogrel … , clopidogrel is …

… may not provide additional benefit in stroke prevention compared with aspirin alone for the
… alleles were at higher risk of vascular events than non-carriers when taking clopidogrel.7 …

… by clopidogrel monotherapy without aspirin, as the treatment of choice for those at very high
risk of … for a select group of primary prevention patients who are at higher risk of CVD but low …

… aspirin antiplatelet therapy in coronary artery disease, and additionally to clopidogrel antiplatelet
therapy in peripheral arterial disease … prevention risk score (high score = higher risk of …

… prevent major adverse cardiovascular events. However, patients treated with CABG still have
a notable risk of … There was no evidence of a higher risk of major bleeding among patients …

… was reported as low risk, some concern, or high risk. … aspirin with clopidogrel while 4
studies compared aspirin with ticagrelor. Six trials enrolled patients with coronary artery disease …

… of major bleeding to varying degrees, with ticagrelor plus aspirin associated with the highest
risk of major bleeding. The net clinical benefit favored clopidogrel or ticagrelor monotherapy…

… than aspirin alone for recurrent stroke prevention with a … search for aspirin plus clopidogrel
or aspirin plus ticagrelor … of stroke, MI, or cardiovascular disease (CVD) death.A, Myocardial …

… as clopidogrel, also have an increased risk of GIB, but by a different mechanism from aspirin,
increasing the risk … a new strategy for the secondary prevention of CHD combined with GID …